GAD-7 Calculator

The Generalized Anxiety Disorder 7-item scale (GAD-7) is a brief, widely validated screening tool that measures how often anxiety-related symptoms have troubled you over the past two weeks. Clinicians commonly use it alongside a full evaluation to gauge anxiety severity and monitor change over time.

Over the last 2 weeks, how often have you been bothered by the following problems?

1Feeling nervous, anxious, or on edge
2Not being able to stop or control worrying
3Worrying too much about different things
4Trouble relaxing
5Being so restless that it is hard to sit still
6Becoming easily annoyed or irritable
7Feeling afraid as if something awful might happen

How the score is calculated

You rate how often each of seven anxiety-related experiences has bothered you over the last two weeks on a 0–3 scale. The seven scores are summed for a total ranging from 0 to 21, with higher totals generally reflecting greater symptom intensity.

Important limitations

  • The GAD-7 screens broadly for anxiety symptoms and does not distinguish between different anxiety disorders (panic, social anxiety, phobias, etc.).
  • It is not a standalone diagnosis and does not account for medical causes of anxiety-like symptoms (e.g., thyroid conditions, stimulant use).
  • Scores can be influenced by acute stressors that are not necessarily a disorder.

Frequently Asked Questions

What is the GAD-7?

A seven-item questionnaire that screens for generalized anxiety symptoms and estimates their severity over the past two weeks.

How is the GAD-7 scored?

Each item is rated 0–3; the seven ratings are summed for a total score from 0 to 21.

Is a high GAD-7 score an anxiety diagnosis?

No. It indicates the level of anxiety symptoms reported, not a clinical diagnosis, which requires a full evaluation.

Can the GAD-7 be used with the PHQ-9?

Yes — many clinicians use both together since depression and anxiety symptoms frequently co-occur. See our combined PHQ-9 + GAD-7 tool.

How often should I retake the GAD-7?

It is commonly repeated every few weeks to monitor symptom trends, particularly during treatment.

Sources & References

Scroll to Top